NCT02166164

Brief Summary

In this prospective trial we aim to investigate the intra-individual and inter-individual variance in secondary hyperalgesia following pain elicited by the experimental pain model: Brief Thermal Sensitization. Furthermore we wish to investigate how precise the psychological tests, Pain Catastrophizing Scale and Hospital Anxiety and Depression Scale predict the size of the area of secondary hyperalgesia.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2014

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2014

Completed
11 days until next milestone

First Submitted

Initial submission to the registry

June 12, 2014

Completed
6 days until next milestone

First Posted

Study publicly available on registry

June 18, 2014

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2015

Completed
Last Updated

January 27, 2015

Status Verified

January 1, 2015

Enrollment Period

7 months

First QC Date

June 12, 2014

Last Update Submit

January 26, 2015

Conditions

Keywords

PainSecondary hyperalgesiathermal sensitizationCatastrophizationAnxiety

Outcome Measures

Primary Outcomes (1)

  • Change in area of secondary hyperalgesia following brief thermal sensitization

    To determine the intra- and inter-individual variance, and the inter- and intra-observer variance of the secondary hyperalgesia areas following brief thermal sensitization on 4 separate experimental days with two different observers.

    Study day 1, 2, 3, and 4. A minimum of 4 weeks.

Secondary Outcomes (6)

  • Score of Pain Catastrophizing Scale

    7 days

  • Score of Hospital Anxiety and Depression Scale

    7 days

  • Score of Subscales of Pain Catastrophizing Scale and Hospital Anxiety and Depression Scale

    7 days

  • Heat-pain-detection threshold registered by degrees celsius

    1 minute per session

  • Pain following Long Thermal Stimulation, evaluated by maximum on the visual analog scale

    1 minute per session

  • +1 more secondary outcomes

Study Arms (1)

Experiemental pain models

EXPERIMENTAL

all study participants will be tested with the same experimental pain models: Brief thermal sensitization, Long thermal stimulation, and Heat-pain-detection threshold.

Other: Brief thermal sensitizationOther: Long thermal stimulationOther: Heat-pain-detection threshold

Interventions

A small area of the skin of the study participants are heated to 45 degree celsius for 3 minutes, followed by evaluation of secondary hyperalgesia.

Also known as: Experimental thermal pain model
Experiemental pain models

A small area of the skin of the study participants are heated to 45 degrees celsius for 1 minute. During the 1 minute period, the study participant will continually report pain on an electronic visual analog scale.

Also known as: Experimental pain model
Experiemental pain models

The threshold for heat pain are evaluated by heating a small area of the study participants skin. When the study participant feels pain, the temperature (degrees celsius) is registered. 4 threshold measurements per session. Heat pain threshold is defined as the average temperature of the 4 measurements.

Also known as: Experimental pain model
Experiemental pain models

Eligibility Criteria

Age18 Years - 35 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Age \>18 years and \<35 years
  • Speak and understand Danish
  • Male gender
  • Test subjects who have understood and signed the informed consent
  • No prescription medicine during the last 30 days

You may not qualify if:

  • Test subjects that cannot cooperate to the test
  • Test subjects with an alcohol and/or substance abuse, assessed by the investigator
  • Test subjects, who have consumed one or several types of analgesics 2 \<days before the study
  • Test subjects, who have consumed antidepressant medication during the last 30 days before the study
  • Test subjects with chronic pain
  • Test subjects with psychiatric diagnoses
  • Test subjects with tattoos on the extremities
  • Body Mass Index of \>30 or \<18

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of anaesthesia and surgery, 4231, Rigshospitalet

Copenhagen, 2100, Denmark

Location

Related Publications (1)

  • Hansen MS, Wetterslev J, Pipper CB, Ostervig R, Asghar MS, Dahl JB. The Area of Secondary Hyperalgesia following Heat Stimulation in Healthy Male Volunteers: Inter- and Intra-Individual Variance and Reproducibility. PLoS One. 2016 May 11;11(5):e0155284. doi: 10.1371/journal.pone.0155284. eCollection 2016.

MeSH Terms

Conditions

PainHyperalgesiaAnxiety Disorders

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsSomatosensory DisordersSensation DisordersNervous System DiseasesMental Disorders

Study Officials

  • Jørgen B Dahl, MD, Doc. Med, Consultant

    Department of anaesthesiology, dep. Z, Bispebjerg Hospital, Denmark

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

June 12, 2014

First Posted

June 18, 2014

Study Start

June 1, 2014

Primary Completion

January 1, 2015

Study Completion

January 1, 2015

Last Updated

January 27, 2015

Record last verified: 2015-01

Locations